sun pharma q1 results: Sun Pharma Q1 preview: Weak Taro show, soft US sales to weigh on earnings

Consolidated net profit is seen declining 1.4% YoY to Rs 2,033 crore. Indias largest pharmaceutical company by market capitalization is scheduled to release its earnings on Thursday.

Related Keywords

Halol ,Gujarat ,India ,Mohali ,Madhya Pradesh ,Sun Pharma ,Cequa Trx ,Taro Pharmaceutical Industries ,Sun Pharmaceutical Industrie ,Drug Administration ,Sun Pharma Q1 Results ,Sun Pharma Q1 Preview ,Sun Pharma Q1 ,Sun Pharma Share Price ,Taro Pharma ,Sun Pharmaceutical ,Systematix ,